<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02728739</url>
  </required_header>
  <id_info>
    <org_study_id>MHL-2016-001</org_study_id>
    <nct_id>NCT02728739</nct_id>
  </id_info>
  <brief_title>Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients</brief_title>
  <acronym>MRAHF</acronym>
  <official_title>Incidence of Significant Mitral Regurgitation in Patients Presenting With Acute Heart Failure: Journey to Tertiary Centre</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Metanoic Health Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Abbott Vascular</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Metanoic Health Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the prevalence of moderate-to-severe Mitral
      Regurgitation (MR) in acute Heart Failure (HF) patients requiring hospital admission.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients admitted with symptoms of HF- (shortness of breath (SOB), peripheral oedema,
      palpitations and irregular heart beats) will be assessed by the Research Team. The level of
      BNP will be checked using a small device (i-STAT BNP) at the bedside. If results of the test
      suggest HF they will undergo special procedure called transthoracic echocardiography (TTE).
      TTE is an ultrasound scan of the heart which will enable the investigators' to grade severity
      of Mitral Regurgitation (MR) as well as strength of the heart muscle. The investigators will
      use bi-plane Simpton's method to calculate left ventricular (LV) ejection fraction (EF).
      Colour Doppler and PISA method will be used to quantify severity of MR or valve leak.
      Simultaneously there will be recording of heart sounds to find out if auscultation is
      reliable in identifying leaky valves.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 6, 2016</start_date>
  <completion_date type="Actual">February 2018</completion_date>
  <primary_completion_date type="Actual">December 29, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Grade 3 and above mitral regurgitation in acute heart failure.</measure>
    <time_frame>12 months</time_frame>
    <description>TTE Grading is done on colour Doppler and proximal isovelocity surface area (PISA) method.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Establish correlation between BNP level and severity of MR in acute HF</measure>
    <time_frame>12 months</time_frame>
    <description>Standard statistical analysis of BNP level and grade of MR severity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The validity of Hospital Episode Statistics (HES) data against prevalence of grade 3-4 MR in the study.</measure>
    <time_frame>12 month</time_frame>
    <description>Standard statistical analysis of 2 sets of data</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">500</enrollment>
  <condition>Acute Heart Failure</condition>
  <condition>Mitral Regurgitation</condition>
  <arm_group>
    <arm_group_label>Acute Heart Failure Patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acute Heart Failure patients with elevated levels of BNP ( &gt;30pg/ml) will undergo Transthoracic Echocardiogram (TTE) for grading of MR severity within 7 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transthoracic Echocardiogram (TTE) Assesment</intervention_name>
    <description>Transthoracic Echocardiogram (TTE) will be carried out on all heart failure patients with elevated BNP level (&gt;30 pg/ ml) for grading of MR severity within 7 days.</description>
    <arm_group_label>Acute Heart Failure Patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute Heart Failure patients admitted to the Hospital

          -  Elevated BNP level (&gt;30pg/ml)

        Exclusion Criteria:

          -  Patients with BNP level (&lt; 30pg/ml)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aigul Baltabaeva, MBBS MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ashford &amp; St Peter's Hospitals NHS Foundation Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St Peter's Hospital, Guildford Road</name>
      <address>
        <city>Chertsey</city>
        <state>Surrey</state>
        <zip>KT16 0PZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>De Bonis M, Maisano F, La Canna G, Alfieri O. Treatment and management of mitral regurgitation. Nat Rev Cardiol. 2011 Nov 22;9(3):133-46. doi: 10.1038/nrcardio.2011.169. Review.</citation>
    <PMID>22105677</PMID>
  </reference>
  <reference>
    <citation>Enriquez-Sarano M, Sundt TM 3rd. Early surgery is recommended for mitral regurgitation. Circulation. 2010 Feb 16;121(6):804-11; discussion 812. doi: 10.1161/CIRCULATIONAHA.109.868083.</citation>
    <PMID>20159841</PMID>
  </reference>
  <reference>
    <citation>Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, Scott C, Schaff HV, Tajik AJ. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005 Mar 3;352(9):875-83.</citation>
    <PMID>15745978</PMID>
  </reference>
  <reference>
    <citation>Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006 Sep 16;368(9540):1005-11.</citation>
    <PMID>16980116</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 24, 2016</study_first_submitted>
  <study_first_submitted_qc>April 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 5, 2016</study_first_posted>
  <last_update_submitted>February 2, 2018</last_update_submitted>
  <last_update_submitted_qc>February 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

